Business · 27/11/2009
FDA Releases Draft Guidance on Review Schedule for Modified Risk Tobacco Products
The Food and Drug Administration (FDA) has released a draft guidance outlining its preliminary review schedule for modified risk tobacco products, aiming to provide clarity for manufacturers, retailers, and FDA staff on the review process under the Federal Food, Drug, and Cosmetic Act.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →